PHG
HealthcareKoninklijke Philips N.V. · Medical - Devices · $26B
What is Koninklijke Philips N.V.?
Koninklijke Philips is a global health technology company headquartered in Amsterdam, serving hospitals, clinicians, and consumers across more than 100 countries.
Philips generates revenue across three segments: Diagnosis & Treatment, Connected Care, and Personal Health. It sells diagnostic imaging systems, patient monitoring tools, sleep and respiratory devices, and consumer products such as power toothbrushes and male grooming solutions. Software and services tied to enterprise diagnostics and electronic medical records round out its portfolio.
The company traces its current structure to 1980 and is listed on US exchanges under the ticker PHG.
- Diagnostic imaging systems (MRI, CT, X-ray)
- Patient monitoring and emergency care solutions
- Sleep and respiratory care devices
- Consumer health and personal care products
Is PHG a Good Stock to Buy?
UQS Score rates PHG as Below Average overall.
Valuation is the standout pillar, rated Good — suggesting the market may already be pricing in the company's challenges. Growth sits at a Neutral rating, indicating neither a clear expansion story nor outright contraction.
Quality, Moat, and Risk all carry Weak ratings, reflecting meaningful structural and operational headwinds across the business.
See the exact pillar breakdown and full financial metrics by signing up for a UQS Pro account. Sign up free →
Past performance does not guarantee future results. UQS Score is based on fundamental data and is not a buy/sell recommendation.
Does PHG pay dividends?
Yes — Koninklijke Philips N.V. pays a dividend.
Philips pays a regular dividend, which may appeal to income-oriented investors. Given the company's Weak Quality and Risk ratings, investors should weigh dividend sustainability carefully against the broader operational challenges the business currently faces.
When does PHG report earnings?
Koninklijke Philips reports earnings on a quarterly cadence, typical for internationally listed equities.
The company's Neutral Growth and Weak Quality ratings suggest recent results have been uneven relative to sector peers. Margin pressures and ongoing restructuring efforts have been recurring themes in recent reporting periods.
For the most recent quarter's results, visit Koninklijke Philips's investor relations page directly.
PHG Price History
-38.8% over 5Y
Monthly close, adjusted for stock splits and dividend reinvestment.
What if I invested in Koninklijke Philips N.V.?
Based on Koninklijke Philips N.V.'s historical closing prices, adjusted for stock splits and dividend reinvestment. Past performance does not guarantee future results. This is for informational purposes only and is not financial advice.
Frequently Asked Questions
What does Koninklijke Philips do?
Philips is a health technology company offering diagnostic imaging equipment, patient monitoring systems, sleep and respiratory devices, and consumer personal care products. It serves hospitals, clinicians, and everyday consumers worldwide through three main business segments.
Does PHG pay dividends?
Yes, Philips pays a regular dividend. Income investors should review the company's investor relations page for the current dividend rate and payment schedule, and weigh the payout against the company's Weak Risk and Quality ratings.
When does PHG report earnings?
Philips reports on a quarterly cadence. For confirmed upcoming earnings dates, check the company's official investor relations page or your brokerage platform, as our data source does not cover specific calendar dates.
Is PHG a good stock to buy?
UQS Score rates PHG as Below Average. Valuation is rated Good, but Quality, Moat, and Risk are all Weak. Whether that trade-off suits your portfolio depends on your risk tolerance and investment goals. The full pillar breakdown is available to Pro members.
Is PHG overvalued?
PHG's Valuation pillar is rated Good, suggesting the stock is not considered expensive relative to its fundamentals at current levels. However, a favorable valuation alone does not offset the Weak ratings seen in Quality, Moat, and Risk.
What is PHG's market cap bracket?
Philips is classified as a large-cap company, reflecting its scale as a globally operating health technology business with a broad product and services portfolio.
Is PHG a long-term quality investment?
As a long-term quality indicator, PHG's Below Average UQS Score — driven by Weak Quality, Moat, and Risk pillars — raises questions about durable competitive positioning. Investors focused on long-term compounding may want to review the full analysis before committing.
What sector does PHG belong to?
Philips operates in the Healthcare sector, specifically within health technology. It spans both medical equipment and consumer health, giving it a broader footprint than pure-play medical device companies.
Unlock Full PHG Analysis
Sign in to unlock the detailed analysis behind the UQS Score.
- ✓View the complete pillar-by-pillar score breakdown for PHG
- ✓Access detailed financial metrics behind each rating
- ✓Compare PHG against sector peers on Quality, Moat, and Risk
- ✓Track score changes as new earnings data is incorporated
Pro Analysis
PHG — Score History
| Date | UQS | Quality | Moat | Growth | Risk | Value | Change |
|---|---|---|---|---|---|---|---|
| May 22, 2026 | 47.6 | 48.6 | 39.0 | 44.1 | 39.5 | 73.1 | -0.1 |
| May 21, 2026 | 47.7 | 48.6 | 39.0 | 44.2 | 39.5 | 73.7 | -0.4 |
| May 17, 2026 | 48.1 | 48.6 | 39.0 | 44.1 | 39.5 | 76.5 | +0.1 |
| May 14, 2026 | 48.0 | 48.6 | 39.0 | 44.1 | 39.5 | 75.7 | +0.5 |
| May 11, 2026 | 47.5 | 48.6 | 39.0 | 44.0 | 39.5 | 72.6 | +2.8 |
| May 7, 2026 | 44.7 | 37.1 | 39.0 | 43.6 | 39.6 | 73.5 | -0.2 |
| May 6, 2026 | 44.9 | 37.1 | 39.0 | 43.6 | 39.6 | 74.7 | 0.0 |
| May 3, 2026 | 44.9 | 37.1 | 39.0 | 43.5 | 39.6 | 74.7 | +0.3 |
| Apr 26, 2026 | 44.6 | 37.1 | 39.0 | 43.5 | 39.6 | 72.9 | +0.4 |
| Apr 19, 2026 | 44.2 | 37.1 | 39.0 | 43.5 | 39.6 | 70.3 | -0.2 |
PHG — Pillar Breakdown
Quality
— 48.6/100 (25%)Koninklijke Philips N.V. has average quality metrics, with room for improvement in margins or capital efficiency.
How effectively capital is deployed to generate returns.
Profitability relative to shareholders' equity.
Ability to convert revenue into operating profit.
Bottom-line profit as a share of revenue.
Asset productivity — how much gross profit each dollar of assets generates.
Free cash flow relative to market value.
Growth
— 44.1/100 (20%)Koninklijke Philips N.V. shows steady but unspectacular growth, typical for mature companies.
Revenue trajectory over the last twelve months.
Compound annual revenue growth rate over 3 years.
Year-over-year earnings per share growth.
Analyst consensus for future revenue growth.
Analyst consensus for future earnings growth.
Risk
— 39.5/100 (15%)Koninklijke Philips N.V. has some risk factors including moderate leverage or solvency concerns.
Debt levels relative to earnings capacity.
Total debt relative to shareholder equity.
Short-term liquidity — ability to pay near-term obligations.
Earnings capacity relative to interest payments.
Valuation
— 73.3/100 (15%)Koninklijke Philips N.V. trades at a reasonable valuation with decent earnings yield and FCF multiples.
Inverse of forward P/E — higher yield means cheaper stock.
How many years of FCF the market cap represents.
P/E relative to earnings growth — lower is more attractive.
Enterprise value multiple relative to sector median.
Moat
— 39/100 (25%)Koninklijke Philips N.V. possesses some competitive advantages but faces meaningful competition. The Moat pillar evaluates competitive advantages across five dimensions: Switching Costs, Network Effects, Cost Advantage, Intangible Assets, and Scale & Ecosystem. Sign in to customize moat ratings for PHG.
Score Composition
Financial Data
More Stock Analysis
How is the PHG UQS Score Calculated?
The UQS (Unified Quality Score) for Koninklijke Philips N.V. is calculated using a proprietary 6-pillar framework with 29 financial metrics. Each pillar evaluates a different dimension on a 0–100 scale, then combines into a single weighted score. Scoring thresholds are calibrated per sector. Momentum is an optional Pro toggle — without it, you get the 5-pillar / 25-metric core shown below.
Quality (25%) measures profitability and capital efficiency — ROIC, ROE, margins, GP/Assets, and FCF Yield.
Moat (25%) assesses Koninklijke Philips N.V.'s competitive advantages across switching costs, network effects, cost advantages, intangible assets, and ecosystem scale.
Growth (20%) tracks revenue trajectory and earnings momentum, combining historical results with analyst forward estimates.
Risk (15%) is inversely scored — lower leverage and strong balance sheet health result in higher scores.
Valuation (15%) measures whether Koninklijke Philips N.V. is fairly priced using earnings yield, price-to-FCF, PEG ratio, and EV/EBITDA relative to sector peers.
Six investor-inspired presets are available, each with different pillar weights: Balanced, Buffett, Munger, Lynch, Cathie Wood, and Graham. The public score shown here uses the Balanced preset. Learn more in our FAQ.